Interestingly, while FLT3 mutations are sufficient to induce gene overexpression, their concurrence with 13q12.2 deletions results in a significantly higher expression that may contribute to the aggressive nature of iAMP21-ALL. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.